Enanta Pharmaceuticals, Inc. Share Price
ENTAEnanta Pharmaceuticals, Inc. Stock Performance
Open $14.83 | Prev. Close $14.58 | Circuit Range N/A |
Day Range $14.70 - $15.15 | Year Range $6.46 - $17.11 | Volume 19,954 |
Average Traded $14.87 |
Enanta Pharmaceuticals, Inc. Share Price Chart
About Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Enanta Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
01-Jul-26 | $14.83 | $14.75 | +0.00% |
01-Jul-26 | $14.83 | $14.75 | +1.34% |
30-Jun-26 | $14.48 | $14.55 | -0.44% |
29-Jun-26 | $14.14 | $14.62 | +4.58% |
26-Jun-26 | $13.71 | $13.98 | +4.17% |
25-Jun-26 | $14.00 | $13.42 | -2.22% |
24-Jun-26 | $13.87 | $13.72 | -2.45% |
FAQs on Enanta Pharmaceuticals, Inc. Share Price
Can I buy Enanta Pharmaceuticals, Inc. shares in India?
What is the share price of Enanta Pharmaceuticals, Inc.?
What is the 5 year returns of Enanta Pharmaceuticals, Inc.?
What are the high & low stock price of Enanta Pharmaceuticals, Inc. today?
What is the 52-week high and low of Enanta Pharmaceuticals, Inc. stock?